

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.03257239 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.01124383 |
| 3 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.66936895 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.53234490 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.53234490 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.50985897 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.50985897 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.50985897 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.50985897 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.50985897 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.50985897 |
| 12 | tolerance induction (GO:0002507) | 4.49343785 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.43935283 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.33723377 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29649649 |
| 16 | microglial cell activation (GO:0001774) | 4.13147346 |
| 17 | detection of other organism (GO:0098543) | 4.02270688 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.01285257 |
| 19 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.94416239 |
| 20 | positive T cell selection (GO:0043368) | 3.89924162 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.87415967 |
| 22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.84173124 |
| 23 | negative thymic T cell selection (GO:0045060) | 3.83626442 |
| 24 | detection of bacterium (GO:0016045) | 3.83246129 |
| 25 | positive regulation of B cell differentiation (GO:0045579) | 3.77388323 |
| 26 | negative T cell selection (GO:0043383) | 3.76355226 |
| 27 | positive regulation of granulocyte differentiation (GO:0030854) | 3.71788365 |
| 28 | B cell receptor signaling pathway (GO:0050853) | 3.62669800 |
| 29 | positive regulation of interferon-alpha production (GO:0032727) | 3.62084118 |
| 30 | regulation of B cell differentiation (GO:0045577) | 3.53226333 |
| 31 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.48666191 |
| 32 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.48666191 |
| 33 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.48563361 |
| 34 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.46074653 |
| 35 | T cell selection (GO:0045058) | 3.43756344 |
| 36 | negative regulation of granulocyte differentiation (GO:0030853) | 3.43561221 |
| 37 | regulation of interferon-alpha production (GO:0032647) | 3.42439131 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.39119448 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.37064689 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.35340493 |
| 41 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.33949063 |
| 42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.33086201 |
| 43 | thymic T cell selection (GO:0045061) | 3.32276693 |
| 44 | cellular response to zinc ion (GO:0071294) | 3.29654104 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28694433 |
| 46 | cellular extravasation (GO:0045123) | 3.27254682 |
| 47 | macrophage activation (GO:0042116) | 3.25648293 |
| 48 | response to type I interferon (GO:0034340) | 3.14854431 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 3.12989383 |
| 50 | response to muramyl dipeptide (GO:0032495) | 3.10046520 |
| 51 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.09016403 |
| 52 | type I interferon signaling pathway (GO:0060337) | 3.07777053 |
| 53 | cellular response to type I interferon (GO:0071357) | 3.07777053 |
| 54 | germinal center formation (GO:0002467) | 3.07543188 |
| 55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.07324769 |
| 56 | negative regulation of cell killing (GO:0031342) | 3.07324769 |
| 57 | neutrophil activation involved in immune response (GO:0002283) | 3.06157699 |
| 58 | immunoglobulin mediated immune response (GO:0016064) | 3.05029276 |
| 59 | neutrophil mediated immunity (GO:0002446) | 3.02863925 |
| 60 | lymph vessel development (GO:0001945) | 3.01675590 |
| 61 | response to host (GO:0075136) | 3.00348677 |
| 62 | response to host defenses (GO:0052200) | 3.00348677 |
| 63 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00348677 |
| 64 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.97798737 |
| 65 | T-helper cell differentiation (GO:0042093) | 2.97798737 |
| 66 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.97063867 |
| 67 | detection of biotic stimulus (GO:0009595) | 2.96586617 |
| 68 | response to host immune response (GO:0052572) | 2.94347418 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.94347418 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 2.93223723 |
| 71 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.91648747 |
| 72 | cellular response to interleukin-15 (GO:0071350) | 2.91487829 |
| 73 | T cell homeostasis (GO:0043029) | 2.91261518 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91150033 |
| 75 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.90813294 |
| 76 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.88450632 |
| 77 | regulation of granulocyte differentiation (GO:0030852) | 2.87793604 |
| 78 | histone H3-K36 demethylation (GO:0070544) | 2.87705058 |
| 79 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.87386929 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85660544 |
| 81 | natural killer cell differentiation (GO:0001779) | 2.84705132 |
| 82 | regulation of T cell tolerance induction (GO:0002664) | 2.83887390 |
| 83 | positive regulation of chemokine secretion (GO:0090197) | 2.82573436 |
| 84 | neutrophil activation (GO:0042119) | 2.82309657 |
| 85 | mature B cell differentiation (GO:0002335) | 2.80724760 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 2.80424513 |
| 87 | histone H3-K4 trimethylation (GO:0080182) | 2.79680838 |
| 88 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79327405 |
| 89 | interferon-gamma production (GO:0032609) | 2.76937298 |
| 90 | positive regulation of interferon-beta production (GO:0032728) | 2.75941490 |
| 91 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.75001373 |
| 92 | regulation of antigen processing and presentation (GO:0002577) | 2.74327059 |
| 93 | response to laminar fluid shear stress (GO:0034616) | 2.73006205 |
| 94 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.71726888 |
| 95 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.71350655 |
| 96 | NIK/NF-kappaB signaling (GO:0038061) | 2.70864771 |
| 97 | regulation of germinal center formation (GO:0002634) | 2.70727930 |
| 98 | keratan sulfate catabolic process (GO:0042340) | 2.69692683 |
| 99 | I-kappaB phosphorylation (GO:0007252) | 2.69653029 |
| 100 | regulation of tolerance induction (GO:0002643) | 2.69421982 |
| 101 | positive thymic T cell selection (GO:0045059) | 2.69382667 |
| 102 | leukocyte degranulation (GO:0043299) | 2.68795561 |
| 103 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.67544078 |
| 104 | T cell migration (GO:0072678) | 2.66604312 |
| 105 | positive regulation of humoral immune response (GO:0002922) | 2.66201201 |
| 106 | positive regulation of B cell activation (GO:0050871) | 2.66137112 |
| 107 | defense response to protozoan (GO:0042832) | 2.65238280 |
| 108 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.64548003 |
| 109 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.63712939 |
| 110 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.63096134 |
| 111 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.62890283 |
| 112 | response to protozoan (GO:0001562) | 2.62674489 |
| 113 | myeloid dendritic cell activation (GO:0001773) | 2.62485886 |
| 114 | activated T cell proliferation (GO:0050798) | 2.62455558 |
| 115 | negative regulation of innate immune response (GO:0045824) | 2.62379966 |
| 116 | leukocyte cell-cell adhesion (GO:0007159) | 2.61800112 |
| 117 | granulocyte activation (GO:0036230) | 2.61373938 |
| 118 | positive regulation of isotype switching (GO:0045830) | 2.60902606 |
| 119 | negative regulation of phagocytosis (GO:0050765) | 2.60423370 |
| 120 | lymphocyte homeostasis (GO:0002260) | 2.60174389 |
| 121 | RNA destabilization (GO:0050779) | 2.59863488 |
| 122 | substrate-dependent cell migration (GO:0006929) | 2.56885890 |
| 123 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.55673240 |
| 124 | response to interleukin-15 (GO:0070672) | 2.54976062 |
| 125 | definitive hemopoiesis (GO:0060216) | 2.53996654 |
| 126 | myeloid leukocyte activation (GO:0002274) | 2.52612029 |
| 127 | hepatocyte apoptotic process (GO:0097284) | 2.51931581 |
| 128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51725716 |
| 129 | myeloid dendritic cell differentiation (GO:0043011) | 2.51243871 |
| 130 | mature B cell differentiation involved in immune response (GO:0002313) | 2.49919198 |
| 131 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.49315646 |
| 132 | angiogenesis involved in wound healing (GO:0060055) | 2.48607067 |
| 133 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.47996825 |
| 134 | regulation of RIG-I signaling pathway (GO:0039535) | 2.47210806 |
| 135 | leukocyte tethering or rolling (GO:0050901) | 2.46710033 |
| 136 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45820849 |
| 137 | lymph node development (GO:0048535) | 2.44972327 |
| 138 | germ cell migration (GO:0008354) | 2.43178773 |
| 139 | leukocyte aggregation (GO:0070486) | 2.41328530 |
| 140 | respiratory burst (GO:0045730) | 2.41046644 |
| 141 | response to peptidoglycan (GO:0032494) | 2.40891180 |
| 142 | regulation of necroptotic process (GO:0060544) | 2.39543894 |
| 143 | negative regulation of interleukin-6 production (GO:0032715) | 2.39371791 |
| 144 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.39302318 |
| 145 | mannose metabolic process (GO:0006013) | 2.39203801 |
| 146 | negative regulation of B cell proliferation (GO:0030889) | 2.37368074 |
| 147 | negative regulation of stress fiber assembly (GO:0051497) | 2.36634838 |
| 148 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.31739913 |
| 149 | dendritic cell differentiation (GO:0097028) | 2.31494136 |
| 150 | negative regulation of interleukin-12 production (GO:0032695) | 2.30814982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.28664817 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.72788647 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.19662057 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.91131549 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.63362621 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.46258023 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.36505305 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34518139 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.26593327 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06778756 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.01353337 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.00496606 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.85323448 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83707401 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70306420 |
| 16 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.69392188 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.63663162 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.42574767 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.39600855 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37914101 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.23512501 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21371395 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.13273050 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.12880157 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11393623 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.10556621 |
| 27 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10076149 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.09842815 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09251272 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04276962 |
| 31 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01453542 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 2.01166024 |
| 33 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.00743807 |
| 34 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.00743807 |
| 35 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.00743807 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97187379 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.88188993 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82248812 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.79828392 |
| 40 | * MYB_26560356_Chip-Seq_TH1_Human | 1.79554473 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77326778 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.75687834 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.75323062 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71973637 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.69434958 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67530391 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66386336 |
| 48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.54395066 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54189784 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50047789 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49431937 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.47684144 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45339559 |
| 54 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.41905988 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41116061 |
| 56 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38130510 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37810264 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37638189 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36714002 |
| 60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.33675103 |
| 61 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.33052835 |
| 62 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32312129 |
| 63 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30446825 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28744487 |
| 65 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.28142247 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26014717 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25038828 |
| 68 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24507776 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24461122 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23567767 |
| 71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.23440080 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22318006 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20687307 |
| 74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.19609781 |
| 75 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18082360 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17773944 |
| 77 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.17399883 |
| 78 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17380388 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13512983 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10669379 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09102773 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07782712 |
| 83 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.06417666 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04086369 |
| 85 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02877668 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02593990 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02305625 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01955310 |
| 89 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.00654873 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98917838 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98643218 |
| 92 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97982344 |
| 93 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97594677 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97161071 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96307151 |
| 96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96138281 |
| 97 | MAF_26560356_Chip-Seq_TH2_Human | 0.95984176 |
| 98 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95573836 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95494312 |
| 100 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94996121 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94433395 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91855454 |
| 103 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.90813742 |
| 104 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89529188 |
| 105 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88955789 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87668083 |
| 107 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87360803 |
| 108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86854836 |
| 109 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.85901956 |
| 110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85023107 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85023107 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81799851 |
| 113 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.81777609 |
| 114 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.81053653 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80816812 |
| 116 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.80815474 |
| 117 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.80427515 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79296419 |
| 119 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.79123296 |
| 120 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78671747 |
| 121 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77081586 |
| 122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.76330681 |
| 123 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.73121646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.70810411 |
| 2 | MP0003724_increased_susceptibility_to | 2.85784287 |
| 3 | MP0000685_abnormal_immune_system | 2.75385101 |
| 4 | MP0005671_abnormal_response_to | 2.71184450 |
| 5 | MP0006082_CNS_inflammation | 2.68638646 |
| 6 | MP0001790_abnormal_immune_system | 2.62528649 |
| 7 | MP0005387_immune_system_phenotype | 2.62528649 |
| 8 | MP0001800_abnormal_humoral_immune | 2.61923664 |
| 9 | MP0009785_altered_susceptibility_to | 2.52243542 |
| 10 | MP0003303_peritoneal_inflammation | 2.48055323 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.46714958 |
| 12 | MP0003436_decreased_susceptibility_to | 2.46113341 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.41601352 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.39267815 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.31740479 |
| 16 | MP0004381_abnormal_hair_follicle | 2.30477254 |
| 17 | MP0002419_abnormal_innate_immunity | 2.24791673 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.23346179 |
| 19 | MP0002723_abnormal_immune_serum | 2.21363472 |
| 20 | MP0005025_abnormal_response_to | 2.14162031 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.09971569 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.08834408 |
| 23 | MP0001819_abnormal_immune_cell | 2.08399808 |
| 24 | MP0006054_spinal_hemorrhage | 2.07897118 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.07130619 |
| 26 | MP0005464_abnormal_platelet_physiology | 2.02092550 |
| 27 | MP0002132_abnormal_respiratory_system | 1.98673215 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.96595058 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.93828190 |
| 30 | MP0008057_abnormal_DNA_replication | 1.89292858 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.84141761 |
| 32 | MP0002006_tumorigenesis | 1.81369714 |
| 33 | MP0001879_abnormal_lymphatic_vessel | 1.79022021 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.78613517 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.76276574 |
| 36 | MP0002398_abnormal_bone_marrow | 1.71220271 |
| 37 | MP0009278_abnormal_bone_marrow | 1.70270587 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.67358785 |
| 39 | MP0000716_abnormal_immune_system | 1.66831721 |
| 40 | MP0001873_stomach_inflammation | 1.66648014 |
| 41 | MP0004947_skin_inflammation | 1.62003761 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.59692301 |
| 43 | MP0002405_respiratory_system_inflammati | 1.59379551 |
| 44 | MP0004510_myositis | 1.59111483 |
| 45 | MP0005451_abnormal_body_composition | 1.57927131 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.57252689 |
| 47 | MP0002254_reproductive_system_inflammat | 1.54736779 |
| 48 | MP0008995_early_reproductive_senescence | 1.52925116 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.52871641 |
| 50 | MP0003279_aneurysm | 1.51517429 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.50841181 |
| 52 | MP0003045_fibrosis | 1.50091506 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.48790821 |
| 54 | MP0000343_altered_response_to | 1.48135538 |
| 55 | MP0003828_pulmonary_edema | 1.46340099 |
| 56 | MP0002722_abnormal_immune_system | 1.45251413 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.40329492 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.39890523 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.39890523 |
| 60 | MP0002429_abnormal_blood_cell | 1.36911940 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.35899400 |
| 62 | MP0001851_eye_inflammation | 1.34764722 |
| 63 | MP0002009_preneoplasia | 1.32487725 |
| 64 | MP0005275_abnormal_skin_tensile | 1.30940330 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.30592220 |
| 66 | MP0002933_joint_inflammation | 1.29251427 |
| 67 | MP0008469_abnormal_protein_level | 1.28816326 |
| 68 | MP0008260_abnormal_autophagy | 1.27328359 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 1.26870146 |
| 70 | MP0000767_abnormal_smooth_muscle | 1.25704230 |
| 71 | MP0005023_abnormal_wound_healing | 1.22335853 |
| 72 | MP0003448_altered_tumor_morphology | 1.20479555 |
| 73 | MP0009764_decreased_sensitivity_to | 1.17028184 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.16144032 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.12991651 |
| 76 | MP0008961_abnormal_basal_metabolism | 1.12851450 |
| 77 | MP0000703_abnormal_thymus_morphology | 1.12007690 |
| 78 | MP0001853_heart_inflammation | 1.11807720 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 1.11393278 |
| 80 | MP0003075_altered_response_to | 1.10693556 |
| 81 | MP0005670_abnormal_white_adipose | 1.08170484 |
| 82 | MP0005390_skeleton_phenotype | 1.02624738 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 1.01274352 |
| 84 | MP0005310_abnormal_salivary_gland | 1.00150180 |
| 85 | MP0000249_abnormal_blood_vessel | 0.99800841 |
| 86 | MP0003091_abnormal_cell_migration | 0.97507467 |
| 87 | MP0005166_decreased_susceptibility_to | 0.95811390 |
| 88 | MP0002928_abnormal_bile_duct | 0.95046016 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.94907309 |
| 90 | MP0000858_altered_metastatic_potential | 0.94308891 |
| 91 | MP0001958_emphysema | 0.93437598 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.91656963 |
| 93 | MP0009115_abnormal_fat_cell | 0.91369326 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.90897678 |
| 95 | MP0004484_altered_response_of | 0.89044356 |
| 96 | MP0005164_abnormal_response_to | 0.87664817 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.84877934 |
| 98 | MP0004130_abnormal_muscle_cell | 0.84059815 |
| 99 | MP0004883_abnormal_blood_vessel | 0.82881369 |
| 100 | MP0009840_abnormal_foam_cell | 0.82738753 |
| 101 | MP0002060_abnormal_skin_morphology | 0.82525820 |
| 102 | MP0003795_abnormal_bone_structure | 0.82408516 |
| 103 | MP0009763_increased_sensitivity_to | 0.80336094 |
| 104 | MP0008004_abnormal_stomach_pH | 0.78308197 |
| 105 | MP0001915_intracranial_hemorrhage | 0.77811721 |
| 106 | MP0003705_abnormal_hypodermis_morpholog | 0.76276785 |
| 107 | MP0002796_impaired_skin_barrier | 0.76164243 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.75660472 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.75646297 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.73039195 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.72749036 |
| 112 | MP0008877_abnormal_DNA_methylation | 0.72566179 |
| 113 | MP0004272_abnormal_basement_membrane | 0.72402236 |
| 114 | MP0003646_muscle_fatigue | 0.72096472 |
| 115 | MP0005503_abnormal_tendon_morphology | 0.71282618 |
| 116 | MP0002135_abnormal_kidney_morphology | 0.68546970 |
| 117 | MP0001243_abnormal_dermal_layer | 0.67400012 |
| 118 | MP0003866_abnormal_defecation | 0.66669944 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.66114401 |
| 120 | MP0010307_abnormal_tumor_latency | 0.65834764 |
| 121 | MP0005334_abnormal_fat_pad | 0.62598683 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.62011828 |
| 123 | MP0000470_abnormal_stomach_morphology | 0.58022074 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.56568669 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.54255776 |
| 126 | MP0006138_congestive_heart_failure | 0.54080887 |
| 127 | MP0005647_abnormal_sex_gland | 0.52794399 |
| 128 | MP0005535_abnormal_body_temperature | 0.52133886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 4.64974225 |
| 2 | Stomatitis (HP:0010280) | 4.57813111 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.37572992 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.18924178 |
| 5 | Hematochezia (HP:0002573) | 3.91986573 |
| 6 | B lymphocytopenia (HP:0010976) | 3.85787928 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.80842900 |
| 8 | Abnormality of B cell number (HP:0010975) | 3.80552602 |
| 9 | Colitis (HP:0002583) | 3.62533593 |
| 10 | Aortic aneurysm (HP:0004942) | 3.60618153 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 3.53372047 |
| 12 | Optic neuritis (HP:0100653) | 3.53372047 |
| 13 | Glomerulonephritis (HP:0000099) | 3.52730712 |
| 14 | Agammaglobulinemia (HP:0004432) | 3.47297279 |
| 15 | Cellulitis (HP:0100658) | 3.43833818 |
| 16 | Cerebral aneurysm (HP:0004944) | 3.41234611 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.41203579 |
| 18 | Myositis (HP:0100614) | 3.34511445 |
| 19 | Spontaneous hematomas (HP:0007420) | 3.32266115 |
| 20 | Arterial tortuosity (HP:0005116) | 3.31390561 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.29925687 |
| 22 | Inflammation of the large intestine (HP:0002037) | 3.24123874 |
| 23 | Granulocytopenia (HP:0001913) | 3.24043264 |
| 24 | Vascular tortuosity (HP:0004948) | 3.20785070 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.20324883 |
| 26 | Recurrent viral infections (HP:0004429) | 3.15166122 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.08945185 |
| 28 | Severe combined immunodeficiency (HP:0004430) | 3.05315537 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 3.04658639 |
| 30 | Abnormality of macrophages (HP:0004311) | 3.04245743 |
| 31 | Recurrent bronchitis (HP:0002837) | 2.92620711 |
| 32 | Chronic otitis media (HP:0000389) | 2.91310171 |
| 33 | Pustule (HP:0200039) | 2.90769280 |
| 34 | Aortic dissection (HP:0002647) | 2.90523957 |
| 35 | IgM deficiency (HP:0002850) | 2.85409867 |
| 36 | Vacuolated lymphocytes (HP:0001922) | 2.83167284 |
| 37 | Obstructive lung disease (HP:0006536) | 2.82619375 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.82619375 |
| 39 | Chest pain (HP:0100749) | 2.77316439 |
| 40 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.75968927 |
| 41 | Recurrent skin infections (HP:0001581) | 2.74680925 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.71604569 |
| 43 | Encephalitis (HP:0002383) | 2.70256394 |
| 44 | Spondylolisthesis (HP:0003302) | 2.70146645 |
| 45 | Complement deficiency (HP:0004431) | 2.67452720 |
| 46 | Meningitis (HP:0001287) | 2.65060596 |
| 47 | Emphysema (HP:0002097) | 2.64055481 |
| 48 | IgG deficiency (HP:0004315) | 2.63987255 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.63370547 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.63370547 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.63370547 |
| 52 | Abnormality of the fingertips (HP:0001211) | 2.62767290 |
| 53 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62645087 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.62328481 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 2.61292093 |
| 56 | Autoimmune hemolytic anemia (HP:0001890) | 2.59775101 |
| 57 | Hypoplasia of the thymus (HP:0000778) | 2.57519352 |
| 58 | Abnormality of eosinophils (HP:0001879) | 2.57356640 |
| 59 | Osteomyelitis (HP:0002754) | 2.54829937 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.54669214 |
| 61 | Chronic diarrhea (HP:0002028) | 2.53471164 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.52661206 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.51507878 |
| 64 | Papilledema (HP:0001085) | 2.50608631 |
| 65 | Nephritis (HP:0000123) | 2.50029286 |
| 66 | Myocardial infarction (HP:0001658) | 2.48488813 |
| 67 | Hemoptysis (HP:0002105) | 2.48365508 |
| 68 | Combined immunodeficiency (HP:0005387) | 2.47882497 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.46890532 |
| 70 | Increased IgE level (HP:0003212) | 2.46086197 |
| 71 | Fatigue (HP:0012378) | 2.43848538 |
| 72 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43391636 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43391636 |
| 74 | Vasculitis (HP:0002633) | 2.43162275 |
| 75 | Stomach cancer (HP:0012126) | 2.40847230 |
| 76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.40068031 |
| 77 | Slow saccadic eye movements (HP:0000514) | 2.39335519 |
| 78 | Panhypogammaglobulinemia (HP:0003139) | 2.38803813 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.38279259 |
| 80 | Orchitis (HP:0100796) | 2.37515876 |
| 81 | Keratoconjunctivitis (HP:0001096) | 2.37194307 |
| 82 | Mucopolysacchariduria (HP:0008155) | 2.34778194 |
| 83 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34778194 |
| 84 | Interstitial pulmonary disease (HP:0006530) | 2.30216766 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28414817 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28414817 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28414817 |
| 88 | Papilloma (HP:0012740) | 2.26972201 |
| 89 | Verrucae (HP:0200043) | 2.26972201 |
| 90 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.26942365 |
| 91 | Viral hepatitis (HP:0006562) | 2.26869551 |
| 92 | Urticaria (HP:0001025) | 2.25640872 |
| 93 | Mitral valve prolapse (HP:0001634) | 2.21431744 |
| 94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.18786730 |
| 95 | Prolonged bleeding time (HP:0003010) | 2.18334411 |
| 96 | Striae distensae (HP:0001065) | 2.18328784 |
| 97 | Lymphopenia (HP:0001888) | 2.17065461 |
| 98 | Hypochromic anemia (HP:0001931) | 2.16648989 |
| 99 | Abnormal platelet function (HP:0011869) | 2.16603815 |
| 100 | Impaired platelet aggregation (HP:0003540) | 2.16603815 |
| 101 | Disinhibition (HP:0000734) | 2.15286725 |
| 102 | Arterial thrombosis (HP:0004420) | 2.14497589 |
| 103 | Abnormality of complement system (HP:0005339) | 2.12904603 |
| 104 | Gingivitis (HP:0000230) | 2.12664845 |
| 105 | Episodic fever (HP:0001954) | 2.11542351 |
| 106 | Eosinophilia (HP:0001880) | 2.11206204 |
| 107 | Sepsis (HP:0100806) | 2.10718132 |
| 108 | Periodontitis (HP:0000704) | 2.09774952 |
| 109 | Leukocytosis (HP:0001974) | 2.08308681 |
| 110 | Thrombocytosis (HP:0001894) | 2.08232255 |
| 111 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.08165312 |
| 112 | Nonimmune hydrops fetalis (HP:0001790) | 2.07681626 |
| 113 | Bicuspid aortic valve (HP:0001647) | 2.07637488 |
| 114 | Axonal loss (HP:0003447) | 2.07546709 |
| 115 | Hypochromic microcytic anemia (HP:0004840) | 2.07508491 |
| 116 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.07029114 |
| 117 | Gingival bleeding (HP:0000225) | 2.06864899 |
| 118 | Nasal polyposis (HP:0100582) | 2.05997859 |
| 119 | Microcytic anemia (HP:0001935) | 2.05676560 |
| 120 | Osteolytic defects of the hand bones (HP:0009699) | 2.05452603 |
| 121 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05452603 |
| 122 | Abnormality of T cell number (HP:0011839) | 2.03560866 |
| 123 | Anorexia (HP:0002039) | 2.02838387 |
| 124 | Subacute progressive viral hepatitis (HP:0006572) | 2.02125922 |
| 125 | Acute myeloid leukemia (HP:0004808) | 2.02001398 |
| 126 | Dilatation of the ascending aorta (HP:0005111) | 2.01723411 |
| 127 | Pulmonary embolism (HP:0002204) | 2.01220564 |
| 128 | Disproportionate tall stature (HP:0001519) | 2.00917837 |
| 129 | T lymphocytopenia (HP:0005403) | 1.99081868 |
| 130 | Epistaxis (HP:0000421) | 1.98594220 |
| 131 | Facial diplegia (HP:0001349) | 1.98560445 |
| 132 | Thick nail (HP:0001805) | 1.98029952 |
| 133 | Polycythemia (HP:0001901) | 1.98003421 |
| 134 | Thyroiditis (HP:0100646) | 1.97840997 |
| 135 | Lymphoma (HP:0002665) | 1.96737533 |
| 136 | Chronic sinusitis (HP:0011109) | 1.96556610 |
| 137 | Urethral obstruction (HP:0000796) | 1.95636877 |
| 138 | Alveolar cell carcinoma (HP:0006519) | 1.95611137 |
| 139 | Abnormality of the peritoneum (HP:0002585) | 1.94822538 |
| 140 | Skin ulcer (HP:0200042) | 1.93602899 |
| 141 | Abnormality of T cells (HP:0002843) | 1.93254283 |
| 142 | Recurrent sinusitis (HP:0011108) | 1.92593490 |
| 143 | Petechiae (HP:0000967) | 1.91628967 |
| 144 | Increased IgM level (HP:0003496) | 1.90954870 |
| 145 | Broad metatarsal (HP:0001783) | 1.90881706 |
| 146 | Abnormality of the pleura (HP:0002103) | 1.89635995 |
| 147 | Restrictive lung disease (HP:0002091) | 1.88343790 |
| 148 | Muscle fiber splitting (HP:0003555) | 1.86484775 |
| 149 | Cardiomegaly (HP:0001640) | 1.85321965 |
| 150 | Amyloidosis (HP:0011034) | 1.83631995 |
| 151 | Abnormality of the thymus (HP:0000777) | 1.82601184 |
| 152 | Hypergammaglobulinemia (HP:0010702) | 1.81036819 |
| 153 | Difficulty running (HP:0009046) | 1.80844595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 4.92249358 |
| 2 | MAP4K1 | 3.46740581 |
| 3 | ERN1 | 2.88688524 |
| 4 | TYK2 | 2.86509818 |
| 5 | PRPF4B | 2.80630257 |
| 6 | KDR | 2.44124879 |
| 7 | MAP3K10 | 2.40562448 |
| 8 | TBK1 | 2.33585718 |
| 9 | STK10 | 2.25502287 |
| 10 | KIT | 2.23768919 |
| 11 | JAK1 | 2.18151779 |
| 12 | CSF1R | 2.16360428 |
| 13 | MAP3K14 | 2.15055481 |
| 14 | JAK3 | 2.07500216 |
| 15 | ZAP70 | 1.94790634 |
| 16 | MAP2K3 | 1.94742099 |
| 17 | RIPK4 | 1.93089256 |
| 18 | IRAK4 | 1.86610119 |
| 19 | IKBKE | 1.84783169 |
| 20 | MAPK15 | 1.72259928 |
| 21 | FLT3 | 1.69529426 |
| 22 | TIE1 | 1.68082407 |
| 23 | RIPK1 | 1.55556234 |
| 24 | BTK | 1.52653470 |
| 25 | CAMK1D | 1.46968663 |
| 26 | IKBKB | 1.44380554 |
| 27 | BLK | 1.41071962 |
| 28 | EPHA3 | 1.40917701 |
| 29 | GRK6 | 1.40836709 |
| 30 | BMPR2 | 1.40011277 |
| 31 | GRK7 | 1.38850696 |
| 32 | KSR2 | 1.37990080 |
| 33 | TRIB3 | 1.37722481 |
| 34 | BRD4 | 1.36081594 |
| 35 | TEC | 1.35751991 |
| 36 | MAP3K1 | 1.34795701 |
| 37 | SYK | 1.32340307 |
| 38 | CSK | 1.28717461 |
| 39 | HCK | 1.28539119 |
| 40 | TXK | 1.28497652 |
| 41 | SIK3 | 1.26406465 |
| 42 | FGFR4 | 1.25331623 |
| 43 | PKN2 | 1.22791015 |
| 44 | IRAK3 | 1.22252945 |
| 45 | LRRK2 | 1.21329826 |
| 46 | ITK | 1.17859918 |
| 47 | MAP3K13 | 1.15644564 |
| 48 | FGFR3 | 1.13896432 |
| 49 | LCK | 1.12578828 |
| 50 | IRAK2 | 1.12323340 |
| 51 | MAP3K2 | 1.10286680 |
| 52 | YES1 | 1.08902353 |
| 53 | MARK2 | 1.08508276 |
| 54 | TRPM7 | 1.04750303 |
| 55 | RPS6KA4 | 1.03057210 |
| 56 | LYN | 1.02450773 |
| 57 | JAK2 | 1.01873971 |
| 58 | CAMK1G | 1.00553372 |
| 59 | TTN | 0.97126119 |
| 60 | EPHB1 | 0.96522513 |
| 61 | EEF2K | 0.94904636 |
| 62 | PDK1 | 0.94569633 |
| 63 | CHUK | 0.93212737 |
| 64 | MAPK12 | 0.92906840 |
| 65 | SGK2 | 0.92741595 |
| 66 | MAP3K3 | 0.90879328 |
| 67 | CLK1 | 0.86117276 |
| 68 | MAP2K2 | 0.86037743 |
| 69 | PIM1 | 0.83500142 |
| 70 | NEK6 | 0.82383526 |
| 71 | CDK9 | 0.81710869 |
| 72 | SGK3 | 0.81407303 |
| 73 | MAPK7 | 0.79211530 |
| 74 | TAOK3 | 0.78646114 |
| 75 | PTK6 | 0.77710773 |
| 76 | MAP3K7 | 0.77175528 |
| 77 | RAF1 | 0.76234115 |
| 78 | SIK1 | 0.73667149 |
| 79 | PDPK1 | 0.73404825 |
| 80 | MAP3K9 | 0.72301906 |
| 81 | OBSCN | 0.72114090 |
| 82 | PASK | 0.71173889 |
| 83 | PIK3CG | 0.70910601 |
| 84 | NLK | 0.70700184 |
| 85 | FES | 0.68495610 |
| 86 | MELK | 0.68347449 |
| 87 | NME2 | 0.67131850 |
| 88 | CDK12 | 0.65496131 |
| 89 | STK24 | 0.64362113 |
| 90 | TGFBR1 | 0.63436712 |
| 91 | MAP3K6 | 0.63039002 |
| 92 | STK4 | 0.62900651 |
| 93 | ARAF | 0.62472738 |
| 94 | TNK2 | 0.60810209 |
| 95 | MAPKAPK3 | 0.58611173 |
| 96 | SIK2 | 0.58096370 |
| 97 | INSRR | 0.56911997 |
| 98 | CDK4 | 0.55116918 |
| 99 | MATK | 0.54673188 |
| 100 | PAK4 | 0.53139161 |
| 101 | RET | 0.51687821 |
| 102 | DMPK | 0.51620329 |
| 103 | RPS6KL1 | 0.48974203 |
| 104 | RPS6KC1 | 0.48974203 |
| 105 | MARK3 | 0.48727826 |
| 106 | TAOK1 | 0.48602162 |
| 107 | MAPKAPK2 | 0.46373011 |
| 108 | ABL1 | 0.45763811 |
| 109 | NEK9 | 0.45223894 |
| 110 | TAOK2 | 0.45203586 |
| 111 | DYRK1B | 0.44752459 |
| 112 | PDGFRB | 0.43243008 |
| 113 | CDK6 | 0.42834319 |
| 114 | IGF1R | 0.41028425 |
| 115 | MAPK3 | 0.40999342 |
| 116 | KSR1 | 0.40609922 |
| 117 | MST4 | 0.40478390 |
| 118 | PTK2B | 0.40339584 |
| 119 | RPS6KA6 | 0.40231993 |
| 120 | GRK1 | 0.39853646 |
| 121 | INSR | 0.39524670 |
| 122 | CAMK4 | 0.38953981 |
| 123 | RPS6KA1 | 0.38915693 |
| 124 | HIPK2 | 0.38224254 |
| 125 | PRKD1 | 0.37987796 |
| 126 | PDGFRA | 0.36433395 |
| 127 | CDC42BPA | 0.36255450 |
| 128 | PRKCQ | 0.36173953 |
| 129 | MAPK4 | 0.35754960 |
| 130 | PRKAA2 | 0.34851626 |
| 131 | ADRBK2 | 0.34630239 |
| 132 | EGFR | 0.33984705 |
| 133 | IRAK1 | 0.33973830 |
| 134 | MOS | 0.32989479 |
| 135 | PRKD2 | 0.32096036 |
| 136 | MAPK11 | 0.31697112 |
| 137 | FRK | 0.31594957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.72207812 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63649040 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.59795840 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57212089 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.31918353 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.26091898 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.22578340 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19003645 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.00084276 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.97104547 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.87673836 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.86917217 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.86110411 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.82864324 |
| 15 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77470569 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 1.74567151 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.71711326 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.70552703 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66809082 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.63392390 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.61707600 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59098578 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55009041 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54535881 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.53094577 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53000687 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.52332722 |
| 28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.50552250 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43598247 |
| 30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42772989 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.42630478 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.42272577 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.39499312 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.39295380 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.38381645 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.34105520 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32810723 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.32018321 |
| 39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.31191492 |
| 40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.28912311 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28146452 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.24545960 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24514221 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22560151 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22410619 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21265046 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.21078563 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.16411105 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14883146 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12489100 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.08935835 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08771504 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08466759 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 1.06570394 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 1.06033100 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 1.04276961 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.03602432 |
| 58 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01054709 |
| 59 | Thyroid cancer_Homo sapiens_hsa05216 | 0.98319639 |
| 60 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96331471 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.94546217 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.94195178 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93855519 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.93606459 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.92625869 |
| 66 | Focal adhesion_Homo sapiens_hsa04510 | 0.89879167 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88185232 |
| 68 | Adherens junction_Homo sapiens_hsa04520 | 0.86827488 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.84842026 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83075521 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.77927624 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77606123 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.77579173 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75112622 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72932495 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71998376 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71636120 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70236987 |
| 79 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68565843 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67983473 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67540797 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67399539 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67268254 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66528005 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66060710 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.64655193 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64447096 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64052117 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63303739 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58328683 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57676626 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57661474 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56074779 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.55413858 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55379117 |
| 96 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53921158 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.53686950 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53141419 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51252691 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50549188 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50547175 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50331575 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.50303868 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48852290 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48069379 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47624614 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46607428 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45568145 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45420334 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43145823 |
| 111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43119269 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42968179 |
| 113 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41643582 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41088946 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40372428 |
| 116 | Lysine degradation_Homo sapiens_hsa00310 | 0.39873688 |
| 117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38722643 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37440012 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37307089 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36555759 |
| 121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.36529543 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35313565 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34867127 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.34370763 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.33508252 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33197792 |

